Compare BridgeBio Pharma Inc (BBIO) vs KraneShares CSI China Internet ETF (KWEB) Price & Performance

BridgeBio Pharma IncTrade

KraneShares CSI China Internet ETFTrade

Price performance (Past 24H)

Key statistics

BridgeBio Pharma Inc vs KraneShares CSI China Internet ETF — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while KraneShares CSI China Internet ETF trades at $26.77. The key difference: BridgeBio Pharma Inc is trading nearer its 52-week high, KraneShares CSI China Internet ETF nearer its low. Which is the better fit depends on your goals.

	BBIO	KWEB
Market Cap	$16.27B	—
Sector	Health	Sector/Thematic
52-Week High	$90.17	$42.94
52-Week Low	$44.81	$23.63
Enterprise Value	$17.82B	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BBIO

BridgeBio Pharma stays a strong buy with key drug approvals and $1B funding boost.Seeking Alpha · 2 days agoBullish View details →

KWEB

Global markets show mixed 2026 gains; Japan's Nikkei leads with 33.6% rise, India lags down 8.9%.ETF Trends · 1 day agoNeutral View details →

About BridgeBio Pharma Inc

BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.

About KraneShares CSI China Internet ETF

KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.